Fibrinolysis for acute myocardial infarction - The future is here and now

被引：47

作者：

Armstrong, PW

Collen, D

Antman, E

机构：

[1] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB T6G 2H7, Canada

[2] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium

[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

来源：

CIRCULATION | 2003年 / 107卷 / 20期

关键词：

D O I：

10.1161/01.CIR.0000072930.64775.DC

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2533 / 2537

页数：5

共 28 条

[1] ANDERSON HR, 2002, AM COLL CARD ANN SCI
[2] Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: A substudy of the GUSTO-III trial
Anderson, RD
White, HD
Ohman, EM
Wagner, GS
Krucoff, MW
Armstrong, PW
Weaver, WD
Gibler, WB
Stebbins, AL
Califf, RM
Topol, EJ
[J]. AMERICAN HEART JOURNAL, 2002, 144 (01) : 81 - 88
[3] Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
Antman, EM
Giugliano, RP
Gibson, CM
McCabe, CH
Coussement, P
Kleiman, NS
Vahanian, A
Adgey, AAJ
Menown, I
Rupprecht, HJ
Van der Wieken, R
Ducas, J
Scherer, J
Anderson, K
Van de Werf, F
Braunwald, E
[J]. CIRCULATION, 1999, 99 (21) : 2720 - 2732
[4] Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial
Antman, EM
Louwerenburg, HW
Baars, HF
Wesdorp, JCL
Hamer, B
Bassand, JP
Bigonzi, F
Pisapia, G
Gibson, CM
Heidbuchel, H
Braunwald, E
Van de Werf, F
[J]. CIRCULATION, 2002, 105 (14) : 1642 - 1649
[5] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
APPLEBY, P
BAIGENT, C
COLLINS, R
FLATHER, M
PARISH, S
PETO, R
BELL, P
HALLS, H
MEAD, G
DIAZ, R
PAOLASSO, E
PAVIOTTI, C
ROMERO, G
CAMPBELL, T
OROURKE, MF
THOMPSON, P
LESAFFRE, E
VANDEWERF, F
VERSTRAETE, M
ARMSTRONG, PW
CAIRNS, JA
MORAN, C
TURPIE, AG
YUSUF, S
GRANDE, P
HEIKKILA, J
KALA, R
BASSAND, JP
BOISSEL, JP
BROCHIER, M
LEIZOROVICZ, A
BRUGGEMANN, T
KARSCH, KR
KASPER, W
LAMMERTS, D
NEUHAUS, KL
MEYER, J
SCHRODER, R
VONESSEN, R
SARAN, RK
ARDISSINO, D
BONADUCE, D
BRUNELLI, C
CERNIGLIARO, C
FORESTI, A
FRANZOSI, MG
GUIDUCCI, D
MAGGIONI, A
MAGNANI, B
MATTIOLI, G
[J]. LANCET, 1994, 343 (8893) : 311 - 322
[6] Armstrong PW, 2001, CIRCULATION, V103, P2862
[7] Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2
Armstrong, PW
Collen, D
[J]. CIRCULATION, 2001, 103 (24) : 2987 - 2992
[8] AVERSANO T, JAMA, V287, P1943
[9] Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
Boersma, E
Maas, ACP
Deckers, JW
Simoons, ML
[J]. LANCET, 1996, 348 (9030) : 771 - 775
[10] Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
Bonnefoy, E
Lapostolle, F
Leizorovicz, A
Steg, G
McFadden, EP
Dubien, PY
Cattan, S
Boullenger, E
Machecourt, J
Lacroute, JM
Cassagnes, J
Dissait, F
Touboul, P
[J]. LANCET, 2002, 360 (9336) : 825 - 829

← 1 2 3 →